Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Inspire Medical Systems Inc (NYSE: INSP) closed the day trading at $93.05 up 0.64% from the previous closing price of $92.46. In other words, the price has increased by $0.64 from its previous closing price. On the day, 0.75 million shares were traded. INSP stock price reached its highest trading level at $93.63 during the session, while it also had its lowest trading level at $91.11.
Ratios:
For a better understanding of INSP, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.38 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.36. For the most recent quarter (mrq), Quick Ratio is recorded 4.01 and its Current Ratio is at 5.29. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On December 02, 2025, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight but kept the price unchanged to $130.
Truist Upgraded its Hold to Buy on November 26, 2025, while the target price for the stock was maintained at $165.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 09 ’26 when Rondoni John sold 109 shares for $100.00 per share. The transaction valued at 10,900 led to the insider holds 13,797 shares of the business.
JOHN RONDONI bought 109 shares of INSP for $10,355 on Jan 09 ’26. On Dec 02 ’25, another insider, mcCormick Shawn, who serves as the Director of the company, sold 1,200 shares for $139.00 each. As a result, the insider received 166,800 and left with 24,846 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 2751890176 and an Enterprise Value of 2413685248. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 63.82, and their Forward P/E ratio for the next fiscal year is 52.66. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.91. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.06 while its Price-to-Book (P/B) ratio in mrq is 4.06. Its current Enterprise Value per Revenue stands at 2.735 whereas that against EBITDA is 48.919.
Stock Price History:
The Beta on a monthly basis for INSP is 0.75, which has changed by -0.46810102 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $203.12, while it has fallen to a 52-week low of $70.77. The 50-Day Moving Average of the stock is -10.58%, while the 200-Day Moving Average is calculated to be -17.70%.
Shares Statistics:
Over the past 3-months, INSP traded about 1.54M shares per day on average, while over the past 10 days, INSP traded about 1105590 shares per day. A total of 29.05M shares are outstanding, with a floating share count of 27.76M. Insiders hold about 4.47% of the company’s shares, while institutions hold 105.27% stake in the company. Shares short for INSP as of 1767139200 were 2907519 with a Short Ratio of 1.89, compared to 1764288000 on 3481719. Therefore, it implies a Short% of Shares Outstanding of 2907519 and a Short% of Float of 13.520001.
Earnings Estimates
. The current assessment of Inspire Medical Systems Inc (INSP) involves the perspectives of 11.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.11, with high estimates of $0.33 and low estimates of -$0.22.
Analysts are recommending an EPS of between $1.65 and $1.54 for the fiscal current year, implying an average EPS of $1.61. EPS for the following year is $1.69, with 11.0 analysts recommending between $2.01 and $1.31.
Revenue Estimates
13 analysts predict $264.54M in revenue. The current quarter. It ranges from a high estimate of $269M to a low estimate of $262.15M. As of. The current estimate, Inspire Medical Systems Inc’s year-ago sales were $239.72MFor the next quarter, 13 analysts are estimating revenue of $214.77M. There is a high estimate of $223.4M for the next quarter, whereas the lowest estimate is $205.21M.
A total of 13 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $911.91M, while the lowest revenue estimate was $905.1M, resulting in an average revenue estimate of $907.63M. In the same quarter a year ago, actual revenue was $802.8MBased on 11 analysts’ estimates, the company’s revenue will be $1B in the next fiscal year. The high estimate is $1.01B and the low estimate is $1B.
